These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39101261)

  • 1. [Do not overuse doxycycline as prophylaxis for uncomplicated sexually transmitted infections].
    Filén F; Eriksen J; Missailidis C
    Lakartidningen; 2024 Aug; 121():. PubMed ID: 39101261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials.
    Szondy I; Meznerics FA; Lőrincz K; Kemény LV; Walter A; Mohammed AA; Hegyi P; Kiss N; Bánvölgyi A
    Int J Infect Dis; 2024 Oct; 147():107186. PubMed ID: 39122208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
    Cornelisse VJ; Riley B; Medland NA
    Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.
    Molina JM; Bercot B; Assoumou L; Rubenstein E; Algarte-Genin M; Pialoux G; Katlama C; Surgers L; Bébéar C; Dupin N; Ouattara M; Slama L; Pavie J; Duvivier C; Loze B; Goldwirt L; Gibowski S; Ollivier M; Ghosn J; Costagliola D;
    Lancet Infect Dis; 2024 Oct; 24(10):1093-1104. PubMed ID: 38797183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections.
    Cannon CA; Celum CL
    Top Antivir Med; 2023 Dec; 31(5):566-575. PubMed ID: 38198668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
    N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Put a little doxy-PEP in your step: Using doxycycline to prevent chlamydia, syphilis, and gonorrhea infections.
    Meyerowitz EA; Liang R; Bishop D; Mullis CE
    PLoS Pathog; 2024 Sep; 20(9):e1012575. PubMed ID: 39348354
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
    Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils.
    Siguier M; Molina JM
    ACS Infect Dis; 2018 May; 4(5):660-663. PubMed ID: 29570279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
    Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM;
    N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.
    Bachmann LH; Barbee LA; Chan P; Reno H; Workowski KA; Hoover K; Mermin J; Mena L
    MMWR Recomm Rep; 2024 Jun; 73(2):1-8. PubMed ID: 38833414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic after sex could help curb infections.
    Cohen J
    Science; 2022 Jul; 377(6605):459. PubMed ID: 35901144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP).
    Werner RN; Schmidt AJ; Potthoff A; Spornraft-Ragaller P; Brockmeyer NH;
    J Dtsch Dermatol Ges; 2024 Mar; 22(3):466-478. PubMed ID: 38123738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.
    Fredericksen RJ; Perkins R; Brown CE; Cannon C; Lopez C; Cohee A; Dombrowski JC; Cohen S; Malinski C; Powell M; Luetkemeyer AF; Celum C; Christopoulos K
    AIDS Patient Care STDS; 2024 Apr; 38(4):155-167. PubMed ID: 38656217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).
    Cornelisse VJ; Ong JJ; Ryder N; Ooi C; Wong A; Kenchington P; Giola M; Donovan B; Dean JA; Molina JM; Medland NA
    Sex Health; 2023 Apr; 20(2):99-104. PubMed ID: 36927481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions about doxycycline post-exposure prophylaxis (Doxy-PEP) as an STI-prevention strategy among gay and bisexual men (GBM) in the United States: Results from a qualitative study.
    Ehsan R; D'Angelo AB; Westmoreland DA; Grov C
    Prev Med; 2024 Jun; 183():107977. PubMed ID: 38692309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of postexposure prophylaxis with doxycycline (Doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis.
    Sokoll PR; Migliavaca CB; Döring S; Traub U; Stark K; Sardeli AV
    Sex Transm Infect; 2024 Aug; ():. PubMed ID: 39097410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Doxycycline as Pre-exposure and/or Post-exposure Prophylaxis to Prevent Sexually Transmitted Diseases: A Systematic Review and Meta-analysis.
    Boschiero MN; Sansone NMS; Ribeiro LM; Marson FAL
    Sex Transm Dis; 2024 Sep; ():. PubMed ID: 39316078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline in the management of sexually transmitted infections.
    Peyriere H; Makinson A; Marchandin H; Reynes J
    J Antimicrob Chemother; 2018 Mar; 73(3):553-563. PubMed ID: 29182717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating changes in antibiotic consumption with the introduction of doxycycline post-exposure prophylaxis in the United States.
    Roster KIO; Grad YH
    medRxiv; 2023 Sep; ():. PubMed ID: 37790567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.